NILO Therapeutics: Funding, Investors & Team (Sep 2026)
NILO Therapeutics is a biotechnology and therapeutics company.
NILO Therapeutics has raised $101M across 1 funding round on record, the most recent a Series A of $101M announced in Oct 2025.
That round is above the $12M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NILO Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
NILO Therapeutics Funding Rounds
NILO Therapeutics Founders and Leadership Team
Contact details for the NILO Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →NILO Therapeutics Funding Compared to Other Biotechnology Startups
NILO Therapeutics' latest round of $101M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NILO Therapeutics in Biotechnology and New York
Companies Similar to NILO Therapeutics
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and…
Rion Vet mission is to drive the regenerative medicine revolution.
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Nomax Therapeutics develops a healthcare technology platform to provide therapies for neurodegenerative…
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate…
Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder…
iOrganBio is a pioneering cell production platform.
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
AccufyDx is a Biotechnology Research firm working to change MRD analysis for early detection.Accufy…
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for…
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Reprogenix is a groundbreaking medical technology firm
NILO Therapeutics Funding FAQs
What does NILO Therapeutics do?
NILO Therapeutics is a biotechnology and therapeutics company.
How much funding has NILO Therapeutics raised?
NILO Therapeutics has raised $101M across 1 round on record. The most recent is a Series A of $101M announced in Oct 2025.
When did NILO Therapeutics last raise funding?
NILO Therapeutics' most recent funding round on record is a Series A of $101M, announced in Oct 2025.
Who is the CEO of NILO Therapeutics?
Kim Seth, Ph.D. is listed as CEO at NILO Therapeutics.
Where is NILO Therapeutics headquartered?
NILO Therapeutics is based in New York, United States.
How many employees does NILO Therapeutics have?
NILO Therapeutics is in the 1-10 employee band.
How does NILO Therapeutics' funding compare to other Biotechnology startups?
NILO Therapeutics' latest round of $101M is above the $12M median round size for Biotechnology companies on FundedIQ across 27 tracked companies over the last two years.
About FundedIQ's NILO Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NILO Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.